[Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].

Dokumenttyp:: Journal Article; Editorial Material
Autor(en):: Ohlmann, C-H; Miller, K; Gschwend, J
Titel:: [Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
Zeitschriftentitel:: Urologe A
Jahr:: 2017
Band / Volume:: 56
Heft / Issue:: 9
Seitenangaben Beitrag:: 1185-1186
Sprache:: de
Volltext / DOI:: doi:10.1007/s00120-017-0464-7
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/28733874
Print-ISSN:: 0340-2592
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: